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Abstract: C. elegans is an invaluable model organism that has been a driving force in many fundamental
biological discoveries. However, it is only in the past two decades that it has been applied to
host–pathogen interaction studies. These studies have been facilitated by the discoveries of natural
microbes that infect C. elegans, including bacteria, fungi and viruses. Notably, many of these microbes
share a common site of infection, the C. elegans intestine. Furthermore, the recent descriptions of a natural
gut microbiota in C. elegans raise the possibility that this could be a novel model system for microbiome
and trans-kingdom interaction studies. Here we review studies of C. elegans host–microbe interactions
with a particular focus on the intestine.
Keywords: host–pathogen interaction; C. elegans; intestine; bacteria; fungi; viruses; microbiome;
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1. Preface
Caenorhabidtitis elegans is a free living nematode found in soil, compost pits and rotting fruits.
It was brought from the field to the lab by Sydney Brenner over 50 years ago [1] and has been used
to address many fundamental biological questions. For example, the Caspase cell death pathway [2]
and RNA interference [3] were first described in C. elegans and were later found to be conserved
in many species including humans. There are many key features that have made C. elegans such
a successful model including: A short lifecycle of approximately three days coupled to a hermaphroditic
lifestyle that facilitates genetics; transparency of the body that enables live fluorescent imaging studies;
a completely defined developmental cell lineage [4]; facile RNAi screening via readily available
whole genome RNAi libraries; it was the first metazoan organism with a completely sequenced
genome [5]; availability of many mutants and transgenic animals to the community via the C. elegans
Genetics Center.
As a differentiated multi-cellular organism, C. elegans mimics many aspects of mammalian
physiology. Of particular relevance to many host–pathogen interactions is the C. elegans intestine,
which as in higher eukaryotes, is the route of exposure and entry of many pathogens. The C. elegans
intestine consists of 20 non-renewable epithelial cells, which make up the majority of its total body
mass during development through the young adult stage. A key similarity between the C. elegans and
human intestine is the presence of polarized epithelial cells with microvilli that are structurally attached
to a terminal web composed of actin and intermediate filaments underneath the apical membrane [6,7].
The C. elegans intestine functions not only to assimilate nutrients, but also has the added function of
detoxifying metabolites and toxins, like the liver in humans. It also consists of the first line of defense
to invading pathogenic microbes. The intestinal lumen consists of the second-largest surface area in
contact with the environment, besides the outer surface cuticle of the C. elegans body.
Here, we review host–microbial interactions in C. elegans with a focus on those that occur in
the intestine.
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2. The C. elegans Microbiome
In nature C. elegans lives in a complex environment, feeding on bacteria and fungi that are present
in soil, compost and rotting fruits. Given this high degree of exposure to microbes, it is likely that
in the wild, the C. elegans intestine may be populated by many different micro-organisms. In one
study, 18 species of bacteria were identified in the microbiota of C. elegans that had been fed on soil
and rotting fruits [8]. Furthermore, they found that the natural microbiota conferred protection from
pathogenic P. aeruginosa infection. In 2016, three groups published papers characterizing the natural
microbiome of C. elegans and found very similar habiting bacteria species in the C. elegans intestine from
geographically different samples over the world [9–12]. The natural microbiome studied was shown to
improve C. elegans growth, resistance to stress and relief from pathogenic bacteria and fungi infections.
These observations parallel recent results in the mouse, demonstrating that “wild” microbiota provide
a fitness advantage and increased resistance to environmental and infectious insults [13].
3. Bacteria–Host Interactions in the C. elegans Gut
Since most of the earliest studies of pathogen–host interactions in the C. elegans model focused
on bacteria, it is natural that there are many reviews on this topic (Figure 1) [7,14–18]. We will focus
specifically on the intestinal response of C. elegans to pathogen infections (Table 1).
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Table 1. Cont.
Kingdoms Pathogens Infection andPathogenic Mode
Host Pathway and Response
in the Intestine Reference(s)
Fungi
N. parisii Feeding; intracellular infection CUL-6, SKR-3, 4, 5 ubiquitinligase pathways [6,28–30]






CED-1, C03F11.3 and ABL-1
dependent pathways [32,33]
Viruses
VSV Infection of primary cellculture or microinjection RNA interference [34–36]
Vaccinia virus PEG permeabilization CED-3 and CED-4 Celldeath pathways [37]







PMK: P38 Map Kinase; ZIP: bZIP (basic Leucine Zipper) domain; FSHR: Follicle Stimulating Hormone Receptor;
LPS: Lipopolysaccharide; DBL: Decapentaplegic/Bone morphogenic protein like; TGF: Transforming Growth Factor;
SEK: SAPK/ERK Kinase; NSY: Neuronal Symmetry; MAP: Mitogen-Activated Protein; TFEB: Transcription factor
EB; CUL: Cullin; SKR: Skp1 Related; CED: Cell death; ABL: Abelson Murine Leukemia; VSV: Vesicular Stomatitis
Virus; PEG: Polyethylene Glycol; STA: Signal Transducer and Activator; CDE: Caffeine Induced Death.
In general terms, there are two major, non-mutually exclusive, mechanisms of bacterial
pathogenesis in C. elegans. One is through secretion of toxins and the other is through direct colonization
of the C. elegans gut lumen. Examples of both of these mechanisms are illustrated by studies using
the well-established Pseudomonas aeruginosa-C. elegans infection model. The “fast killing” mode is
mediated by the bacterial toxin when it is grown on high osmolality rich medium while a “slow killing”
mode is observed when bacteria colonize the intestinal lumen [19]. Many bacteria produce or secrete
different kinds of toxins to interact with the host that can cause pathophysiological changes to the host.
For example, the pore forming toxins produced by Baccillus thyrogensis can perforate the C. elegans
intestinal membrane, causing intestinal distention and animal death [53,54]. Yersinia bacteria encode
an insecticidal toxin in a gene, tcaA, which is genetically required for its toxicity to C. elegans [55].
Burkholderia also produce toxins to kill C. elegans [56,57]. Enterococcus faecalis express cytolysin that
will lyse the host cells of infected C. elegans [58]. Serratia marcescens infection is also thought to kill
by a toxin, suggested by genetic studies to be hemolysin [24]. Studies using Staphylococcus aureus
showed that secreted α-hemolysin can lyse C. elegans cells just as it can lyse mammalian cells [25,26].
Streptococcus pyogenes and other Streptococcus species can synthesize hydrogen peroxide which is
sufficient to kill the infectedC. elegans [27]. Many of these toxin producing bacteria also exert pathogenic
effects on C. elegans via colonization of the intestinal lumen. By contrast, Listeria monocytogenes does
not appear to produce any toxins and causes C. elegans death exclusively through its accumulation in
the C. elegans intestine [59].
In the face of these pathogenic bacteria, C. elegans, like all hosts, has evolved multiple layers of
defenses. At the organismal level, a behavioral response to avoid specific bacterial pathogens has
been described [60,61]. In addition, C. elegans has physical defenses such as the pharynx grinder
that disrupts most bacterial and the intestinal membrane that serves as a barrier to infection [62].
There are also innate immune defense mechanisms that are induced to counteract bacterial infections
(model in Figure 2). C. elegans expresses different antimicrobial peptides, caenopores, lysozymes,
lectins and reactive oxygen species as effector molecules to either detoxify the bacteria toxins or
directly kill the invading bacteria (reviewed in [16,63]). A central question that has attracted significant
scrutiny, but remains elusive, is the identity of the C. elegans pattern recognition receptor(s) (PRR)
responsible for detecting bacterial infection. C-type lectins and chemoreceptors were proposed to
be C. elegans pathogen recognition receptors based on their importance in recognition of pathogen
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associated molecular patterns (PAMPs) in other organisms [64,65]. It is also possible that detection
relies on sensing perturbations of core host processes (also referred to as effector triggered immunity
or damage associated molecular patterns (DAMPs)) induced by bacterial toxins [66]. In contrast to
the uncertainties associated with the pathogen recognition step, the signaling cascades downstream
of recognition have been extensively characterized. The canonical p38 PMK-1 (P38 Map Kinase-1)
MAP (Mitogen-Activated Protein) kinase pathway is critical in C. elegans for defense against many
bacterial infections as well as eukaryotic pathogens [20,23,67–70]. Other pathways including the
TGFβ/DBL-1 (Transforming Growth Factor β/Decapentaplegic/Bone morphogenic protein like-1)
and insulin signaling/DAF-2 (Dauer Formation abnormal-2) pathways have also been reported to be
involved in the response to bacterial infections [71]. The G-protein coupled lectin like receptor FSHR-1
(Follicle Stimulating Hormone Receptor-1) was shown to be required for immune response during
P. aeruginosa infection in C. elegans intestine [21]. A number of key transcription factors that regulate
bacterial pathogen response have been reported, including the ZIP-2/ATFS-1 (bZIP transcription
factor-2/Activating Transcription Factor associated with Stress-1) bZIP (Basic Leucine Zipper)
transcription factors [22,72], DAF-16 FOXPO (Forkhead box protein O) transcription factors [73],
GATA transcription factor ELT-2 (Erythroid-Like Transcription factor-2) [74] and the TFEB/HLH-30
(Transcription factor EB/Helix Loop Helix-30) transcription factors [75].
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4. Fungi–Host Interac ions in the C. elegans Gut
N. parisii, a natural microsporidial pathogen of C. elegans, was discovered in 2008 [6]. N. parisii was
the first intracellular pathogen of the C. elegans intestine to be identified, in contrast to the previously
studied bacterial pathogens which colonize in the intestinal lumen but generally do not infect the
intestinal cells. Microsporidia infection significantly alters the C. elegans intestinal structure [6,28,29].
During the microsporidia lifecycle, meronts form inside the infected C. elegans intestinal cells and then
exit the infected cells non-lytically by remodeling the intestinal terminal web [30]. In analyzing the
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transcriptional response of C. elegans to N. parisii infection, multiple Skr-Cullin-F-box protein ubiquitin
ligase components were found to be highly upregulated. The cullin cul-6 and Skp-1-related genes, skr-3,
4, 5 were found to be important for ubiquitin targeting of N. parisii to the autophagy and proteasome
degradation pathways [29].
The opportunistic human pathogen Candida albicans can infect the C. elegans intestine.
Pukkila-Worley et al. established a model infection system in C. elegans to understand the host factors
that control susceptibility to candidiasis [31]. They found that the yeast form of C. albicans can infect
intestinal cells and cause distal intestinal distention. By contrast, heat killed C. albicans are avirulent,
suggesting that the pathogenesis is not mediated by toxins. Analysis of the transcriptional response
demonstrated that both live and heat killed C. albicans induced a similar response suggesting the host
response is meditated by recognition of a fungal motif that is not dependent on growth. As the host
response to C. albicans infection showed minimal overlap with the responses to pathogenic bacteria
such as S. aureus and P. aeruginosa [31], it appears that C. elegans can distinguish between the invading
pathogens and mount distinct transcriptional responses to different pathogens.
In contrast to what is observed with Candida, both live and heat killed Cryptococcus neoformans
are lethal for C. elegans, suggesting that the pathogen kills the host by production of virulence
factors [32,33].
Other natural fungal pathogens of C. elegans, such as Drechmeria coniospora, that infect the
cuticle rather than the intestine have also been studied [76]. A host G-protein coupled receptor,
DCAR-1 (Dihydrocaffeic Acid Receptor-1), was found to regulate the antifungal response by binding
to an endogenous ligand [77]; the classic p-38 MAP Kinase PMK-1 pathway is implicated in
downstream steps.
5. Virus–Host Interactions in the C. elegans Gut
From its initial establishment as a model until earlier this decade, there were no known viruses
that could naturally infect C. elegans. Therefore, the first studies of virus–host interactions in C. elegans
relied upon surrogate systems that included analysis of C. elegans cells, artificial infection conditions,
or replicons [78,79]. Specifically, these entailed studies of vesicular stomatitis virus (VSV) infection of
primary C. elegans cell culture [34,35], artificial virus infection in C. elegans using vaccinia virus [37],
and a flock house virus transgenic system [38] (Table 1).
In 2005, two groups published papers using VSV infection of C. elegans primary cells.
GFP (Green Fluorescent Protein)-encoding strains of VSV virus replicated to higher levels in cells
derived from the RNAi deficient mutant rde-1 and rde-4 while the replication was inhibited in cells
derived from mutants exhibiting enhanced RNAi responses, such as rrf-3 and eri-1, demonstrating that
RNAi is antiviral in C. elegans [34,35]. In parallel, a flock house virus replicon system was established
that similarly identified RNAi as an antiviral pathway in C. elegans [38]. The Flock house virus B2
protein acts as an RNAi antagonist by binding double stranded RNA which then prevents Argonaute
protein binding [39]. Lu et al. found that the flock house transgenic virus replication in the N2
wild type C. elegans was inhibited when the B2 protein was removed from the transgenic system,
but replication of this mutant was restored in the rde-1 RNAi deficient mutant [38,40]. A subsequent
RNAi screen identified host factors in the RNAi pathway that are important for the control of virus
replication, such as rde-1, rde-4, dcr-1, rsd-2 and drh-1 [40]. Both of these approaches were innovative
and provided novel insights into the role of RNAi in C. elegans; however, there are also limitations to
both. For the former, the cumbersome nature of isolating and maintaining embryonic cells [80,81] has
precluded widespread use of the primary cell system to interrogate host–virus interactions in C. elegans.
For the latter approach, replicon systems cannot be used to study multiple aspects of the viral lifecycle,
such as viral assembly, egress or transmission.
As an alternative approach, polyethylene glycol (PEG) treatment of C. elegans enabled vaccinia
virus to enter and then replicate [37]. Mutants in the cell death pathway lacking ced-3 and ced-4 were
found to be more susceptible to vaccinia virus infection. This study highlighted a non-RNAi pathway
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that acts to restrict virus infection in C. elegans. Interestingly, when using a vaccinia virus that expresses
β-galactosidase, the authors found blue X-gal staining in intestine in all infected animals, suggesting
that the intestine is the primary site of infection in this model. To date no additional studies have been
published using this system.
The first natural virus of C. elegans was not discovered until 2011 [41]. Through field sampling
of wild nematodes and next-generation sequencing (NGS), three Caenorhabditis nematode viruses,
Orsay virus, Santeuil virus, and Le Blanc virus, were isolated and identified [41,42]. All three viruses
specifically infect intestinal cells [43] and share similar morphological disease symptoms that primarily
affected the intestine including convolution of the intestine, loss of gut granules and fusion of intestinal
cells [41]. Orsay virus can infect C. elegans strains, including the laboratory N2 strain, while Santeuil
and Le Blanc virus infect wild C. Briggsae strains but not any tested C. elegans strains. To date, Orsay
virus is still the only known virus that can naturally infect C. elegans. Genome characterization
showed that these viruses share some similarity to nodaviruses [44]. RNAi pathway mutants such as
rde-1, rde-4 and drh-1, supported about 100-fold more virus replication than the wild type N2 strain,
unambiguously demonstrating that in C. elegans RNAi plays a role in antiviral immunity against
an authentic C. elegans viral pathogen [41,45,46]. While many viruses of plants and animals encode
antagonists of the RNAi pathway, there is no evidence to date that Orsay virus encodes an RNAi
antagonistic protein [47]. Subsequent studies found that the wild JU1580 C. elegans strain from which
Orsay virus was initially isolated carries a deletion polymorphism in the drh-1 gene which makes this
strain highly virus-susceptible [45]. Interestingly DRH-1 (Dicer Related Helicase-1) is distantly related
to the mammalian protein RIG-I (Retinoic Acid Inducible Gene-I), which plays a critical role in sensing
of RNA viruses and subsequently triggering antiviral interferon induction. It appears that DRH-1
shares a conserved function in sensing intracellular viral RNA, but rather than inducing interferon
or an interferon-like gene in C. elegans, DRH-1 is critical for antiviral RNAi activity. In fact, domain
swapping experiments demonstrated that the helicase domain and C-terminal regulatory domain
(CTD) of RIG-I could functionally substitute for the corresponding DRH-1 domain in C. elegans [46].
Independent of RNAi, a recent genetic screen identified a novel antiviral mechanism that requires
CDE-1 (Caffeine Induced Death-1), a terminal uridylyltransferase [48].
Multiple studies have defined the transcriptional response to Orsay virus infection [29,49,50].
Given that Orsay infection is limited to the intestinal cells, these results most likely represent
transcriptional changes within the intestine. A particularly noteworthy aspect of these studies
is that Orsay virus infection and microsporidial infection by N. parisii induced a shared set of
genes [29,50]. The cul-6, skr-3 dependent ubiquitin pathway was found to be induced by both
pathogens. RNAi knockdown of cul-6 led to increased Orsay virus infection [29]. In addition, by further
comparing the responses of C. briggsae to Le Blanc and Santeuil virus infection, a set of evolutionarily
conserved nematode genes that respond to virus infection was defined [50]. Intriguingly, the functions
of the majority of these genes are currently unknown, so it is not clear whether these are antiviral genes
or genes necessary for viral (and potentially microsporidial) proliferation. In this set, multiple paralogs
in the pals gene family [82], which has undergone significant expansion in C. elegans [83], were highly
upregulated. While no clear function for any of these genes in relationship to virus infection has been
defined, some of these genes have recently been implicated in regulating protein homeostasis [84].
In an effort to define the regulation of the transcriptional response to Orsay virus infection,
promoter motif finding yielded a consensus resembling that of the STA-1 (Signal Transducer and
Activator-1) transcription factor [51]. STA-1 is orthologous to mammalian STAT1 (Signal Transducer
and Activator of Transcription1), which is a key signaling intermediate essential for interferon signaling
in mammals. Mutant C. elegans lacking STA-1 were more resistant to Orsay infection than WT animals,
suggesting that STA-1 acts as a negative regulator of the C. elegans antiviral response, in contrast
to the positive regulatory role of the mammalian STAT1. Because STAT1 is known to be regulated
by phosphorylation, a targeted kinase RNAi screen in C. elegans was pursued that identified SID-3
(Systemic RNA Interference Defective-3), a non-receptor tyrosine kinase [85], as a candidate regulator
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of STA-1 [51]. Strikingly, sid-3 was simultaneously identified as a gene required for Orsay virus
infection through an independent genetic screen [52]. That study also identified another gene, viro-2,
which is orthologous to human Wiskott Aldrich Syndrome proteins (WASP), as being required for
Orsay virus infection. Both of these genes were required for an early stage of Orsay virus infection;
thus these genes may play key roles in entry of Orsay virus from the intestinal lumen.
Recently, direct VSV virus particle injection into C. elegans animals was demonstrated to lead to
virus replication [36], raising the possibility that this strategy could be used to study a wide range
of viruses in C. elegans. In this study, unique tissue tropism for muscle was observed following
VSV injection, demonstrating that virus infection of non-intestinal cells in C. elegans is possible.
In addition, virus replication was observed in intestinal tissue in drh-1 mutant background. A limitation
of this strategy is the apparent inability of infected animals to transmit infection to other animals,
thus requiring direct microinjection of each individual animal to be analyzed.
6. C. elegans as a Model to Study Microbial Trans-Kingdom Interactions
To date, only a limited number of studies have attempted to directly study interactions of microbes
from more than one kingdom in C. elegans. In one study infection by the fungal pathogen C. albicans
suppressed anti-bacterial response in C. elegans [31], suggesting that Candida infected C. elegans may be
more susceptible to bacterial superinfection. In another study, co-infection with C. albicans and many
other gram-negative bacteria all showed that secondary infection of bacteria can inhibit the fungal
growth [86,87]. With the discoveries of natural bacterial, fungal and viral pathogens of C. elegans, it is
now possible to further explore potential trans-kingdom interactions. To date, there have been no
studies that evaluated potential virus–fungi interactions or virus–bacterial interactions. For example,
although it is known that both N. parisii and Orsay virus can infect intestinal cells, there have been
no published reports evaluating potential interference or synergy in co-infection or superinfection
models. Similarly, there are no reports comparing the impact of a “wild” microbiome vs standard
OP50 E. coli on viral infection. Given the ease with which “germ-free” C. elegans can be generated by
bleaching, coupled to the ability to readily control which bacterial species it is exposed to, C. elegans
may be a very attractive model to define the function of the microbiome, and its interactions with the
host and other fungal and viral agents.
7. Conclusions
C. elegans, as a simple eukaryotic model organism, provides a tremendous opportunity to define
fundamental host–microbe interactions. Starting with the pioneering studies of bacterial pathogenesis,
there have now been parallel efforts to use this model to elucidate evolutionarily conserved principles
of fungal and viral pathogenesis. There is undoubtedly still much to be learned from these individual
systems. However, the time is now ripe to also begin using this model to explore the more nuanced and
complex world beyond mono-infection, in order to define the relationships and impacts of microbes
on each other.
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